SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-051033
Filing Date
2020-04-24
Accepted
2020-04-24 16:38:54
Documents
9
Period of Report
2020-04-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2016791d1_8k.htm 8-K 26648
2 EXHIBIT 1.1 tm2016791d1_ex1-1.htm EX-1.1 106911
3 EXHIBIT 1.2 tm2016791d1_ex1-2.htm EX-1.2 219262
4 EXHIBIT 4.1 tm2016791d1_ex4-1.htm EX-4.1 112476
5 EXHIBIT 4.2 tm2016791d1_ex4-2.htm EX-4.2 116624
6 EXHIBIT 99.1 tm2016791d1_ex99-1.htm EX-99.1 13740
7 EXHIBIT 99.2 tm2016791d1_ex99-2.htm EX-99.2 13126
8 GRAPHIC image_001.jpg GRAPHIC 16179
9 GRAPHIC image_002.jpg GRAPHIC 2129
  Complete submission text file 0001104659-20-051033.txt   635560
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50626 | Film No.: 20815591
SIC: 2834 Pharmaceutical Preparations